Thực trạng mang vi rút viêm gan B trên phụ nữ mang thai và kết quả can thiệp dự phòng tại thành phố Hải Phòng năm 2017-2020

101.Chao S.D., Cheung C.M., Chang E.T., et al. (2019). Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians. BMC Pregnancy Childbirth, 19.

102.World Health Organization (2019). Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine, 37(2), 223–225.

103.(1992), Weekly epidemiological record. No 317, .

104.WHO. Expanded Programme on Immunization (2009), Global summary.

Vaccine - preventable diseases: monitoring system. 2009, .

105.WHO (2015). Immunization coverage: . Fact sheet No. 378. .

106.Childs L., Roesel S., and Tohme R.A. (2018). Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015. Vaccine, 36(1), 6–14.

107.Minta A.A., Silva M.W.T., Shrestha A., et al. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018. Vaccine, 39(14), 1982–1989.

108.Nguyen T.H., Vu M.H., Nguyen V.C., et al. (2014). A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine, 32(2), 217–222.

Có thể bạn quan tâm!

Xem toàn bộ 208 trang tài liệu này.

109.Ork V., Woodring J., Shafiqul Hossain Md., et al. (2019). Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Vaccine, 37(35), 5059–5066.

110.Duong T.H., Nguyen P.H., Henley K., et al. (2009). Risk Factors for Hepatitis B Infection in Rural Vietnam. Asian Pac J Cancer Prev, 10(1), 97–102.

111.CDC (2020). Hepatitis B Vaccination of Infants, Children, and Adolescents. .

112.Wang C., Wang C., Jia Z.-F., et al. (2016). Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine (Baltimore), 95(34), e4390.

113.Public Health England (2016), National antenatal infections screening monitoring, .

114.May S., Mandal S., Keel P., et al. (2018). Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales. The Journal of Infectious Diseases, 218(5), 726–733.

115.Miyakawa M., Yoshida L.-M., Nguyen H.-A.T., et al. (2019). Hepatitis B virus infection among pregnant mothers and children after the introduction of the universal vaccination program in Central Vietnam. Sci Rep, 11, 8676.

116.Wang M., Bian Q., Zhu Y., et al. (2019). Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Aliment Pharmacol Ther, 49(2), 211–217.

117.Singh A.E., Plitt S.S., Osiowy C., et al. (2011). Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. Journal of Viral Hepatitis, 18(7), 468–473. 118.Xu W.-M., Cui Y.-T., Wang L., et al. (2009). Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral

Hepat, 16(2), 94–103.

119.European Association for the Study of the Liver (2012). EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology, 57(1), 167–185.

120.Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding - PubMed. , accessed: 01/07/2021.

121.Viganò M., Mangia G., and Lampertico P. (2014). HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?. Liver International, 34(s1), 120–126.

122.Hl C., Cn L., Ch C., et al. (2015). Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology, 62(2), 375–386.

123.Dunkelberg J., Berkley E., Thiel K., et al. (2014). Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol, 34(12), 882–891.

124.Shi Z., Li X., Ma L., et al. (2010). Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission— a meta-analysis. International Journal of Infectious Diseases, 14(7), e622– e634.

125.Xiao X.M., Li A.Z., Chen X., et al. (2007). Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet, 96(3), 167–170.

126.Jin H., Zhao Y., Tan Z., et al. (2014). Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials. BMC Pediatr, 14.

127.Yuan J., Lin J., Xu A., et al. (2006). Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat, 13(9), 597–604.

128.Piratvisuth T. (2013). Optimal management of HBV infection during pregnancy. Liver Int, 33, 188–194.

129.Giles M.L., Grace R., Tai A., et al. (2013). Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care. Aust N Z J Obstet Gynaecol, 53(3), 231–235.

130.Aysha Aslam, Karen Joanie Campoverde Reyes et al (2018). Management of chronic hepatitis B during pregnancy. Gastroenterol Rep (Oxf), 6(4), 257–262.

131.(2015). Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. The Lancet Infectious Diseases, 15 (8): 981- 985.

132.Adeyemi A.B., Enabor O.O., Ugwu I.A., et al. (2013). Knowledge of hepatitis B virus infection, access to screening and vaccination among pregnant women in Ibadan, Nigeria. J Obstet Gynaecol, 33(2), 155–159.

133.Yang E.J., Cheung C.M., So S.K.S., et al. (2013). Education and Counseling of Pregnant Patients with Chronic Hepatitis B: Perspectives from Obstetricians and Perinatal Nurses in Santa Clara County, California. Asian Pacific Journal of Cancer Prevention, 14(3), 1707–1713.

134.Willis B.C., Wortley P., Wang S.A., et al. (2010). Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics, 125(4), 704–711.

135.Chao S.D., Cheung C.M., Yang E.J., et al. (2012). Low levels of knowledge and preventive practices regarding vertical hepatitis B transmission among perinatal nurses. J Obstet Gynecol Neonatal Nurs, 41(4), 494–505.

136.Clayton S., Yang H., Guan J., et al. (1993). Hepatitis B control in China: knowledge and practices among village doctors. Am J Public Health, 83(12), 1685–1688.

137.Gebrecherkos T., Girmay G., Lemma M., et al. (2020). Knowledge, Attitude, and Practice towards Hepatitis B Virus among Pregnant Women Attending Antenatal Care at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. International Journal of Hepatology.

138.Chen Y., Xie C., Zhang Y., et al. (2018). Knowledge regarding hepatitis B mother-to-child transmission among healthcare workers in South China. J Viral Hepat, 25(5), 561–570.

139.Chan O.K., Lao T.T., Suen S.S.H., et al. (2012). Deficient Knowledge on Hepatitis B Infection in Pregnant Women and Prevalence of Hepatitis B Surface Antigen Carriage in an Endemic Area: A Review. Hepatitis Research and Treatment, 2012, e317451.

140.Muhammad A.A., Ibrahim B.C., and Ramadan A.M. (2016). Knowledge, Attitude and Practice Regarding Hepatitis B Infection among Nurses in Public Hospitals of Niger State, Nigeria. International Journal of tropical disease & Health, 1–9.

141.Frederick Dun-Dery, Martin Nyaaba Adokiya (2017). Assessing the knowledge of expectant mothers on mother–to-child transmission of viral hepatitis B in Upper West region of Ghana. BMC Infectious Diseases, 416 (17).

142.Bộ Y tế (2014), Tài liệu “Hướng dẫn quy trình kỹ thuật chuyên ngành hoá

sinh,” .

143.Nguyễn Thị Loan, Lê Thị Thanh Xuân, Dương Thị Hồng, và CS (2019). Thực trạng tiêm vắc xin viêm gan B sơ sinh ở trẻ dưới 12 tháng tuổi tại huyện Quỳnh Nhai, tỉnh Sơn La năm 2019. Tập 29, số 10: 77.

144.Bộ Y tế (2014). Quyết định 5448/QĐ-BYT về Hướng dẫn chẩn đoán điều trị bệnh viêm gan vi rút B. .

145.Bộ Y tế (2018). Quyết định 7130/QĐ-BYT 2018 Kế hoạch loại trừ HIV viêm gan B giang mai lây truyền từ mẹ sang con. .

146.Bộ Y tế (2019). Kế hoạch phòng chống viêm gan vi rút giai đoạn 2015- 2019. , accessed: 06/29/2021.

147.Hou J., Liu Z., and Gu F. (2005). Epidemiology and Prevention of Hepatitis B Virus Infection. International Journal of Medical Sciences, 2(1), 50.

148.Liu J., Zhang S., Wang Q., et al. (2017). Prevalence of HBsAg/HBeAg amongst 1 936 801 couples preparing for pregnancy in rural China: An observational study. J Viral Hepat, 24(8), 679–686.

149.Scientific Reports Status of HBsAg seroprevalence in 15 million rural couples in China: a cross-sectional study, .

150.Schweitzer A., Horn J., Mikolajczyk R.T., et al. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet, 386(10003), 1546–1555.

151.Yamada H., Fujimoto M., Svay S., et al. (2015). Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia. Hepatol Res, 45(4), 480–487.

152.Hipgrave D.B., Nguyen T.V., Vu M.H., et al. (2003). Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg, 69(3), 288–294.

153.Wang Y., Zhou H., Zhang L., et al. (2017). Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci Rep, 7.

154.Phí Đức Long, Nguyễn Thị Vinh Hà, Nguyễn Văn Bàng. (2011). Nghiên cứu tình trạng nhiễm virut viêm gan B ở phụ nữ có thai tại thành phố Thái Bình và khả năng lây truyền từ mẹ sang con. Tạp chí Y học thực hành.

155.Kubo A., Shlager L., Marks A.R., et al. (2014). Prevention of Vertical Transmission of Hepatitis B: An Observation Study. Ann Intern Med, 160(12), 828–835.

156.Wen W.-H., Chang M.-H., Zhao L.-L., et al. (2013). Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention. Journal of Hepatology, 59(1), 24–30. 157.Chen H.-L., Wen W.-H., and Chang M.-H. (2017). Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission. The Journal of Infectious Diseases, 216(suppl_8), S785–

S791.

158.Chen T., Wang J., Qiu H., et al. (2018). Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-). Medicine (Baltimore), 97(27).

159.Guo Y., Liu J., Meng L., et al. (2010). Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis, 10, 26.

160.Lee L.Y., Lee G.H., Mattar C., et al. (2019). Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia. Pediatrics & Neonatology, 60(5), 517–522.

161.Zhang L., Gui X.-E., Wang B., et al. (2016). Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis, 16.

162.Elefsiniotis I.S., Tsoumakas K., Papadakis M., et al. (2011). Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection. European Journal of Internal Medicine, 22(2), 182–186.

163.World Health Organization (2017). Hepatitis B vaccines: WHO position paper. Weekly Epidemiological Record. .

164.Eric E Mast, Cindy M Weinbaum (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep, 55(RR-16):1-33.

165.Boucheron, P., Lu, Y., Yoshida, K., Zhao, T., Funk, A. L., Lunel-Fabiani, F., … Shimakawa, Y. (2020). Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. The Lancet Infectious Diseases.

166.Wiseman E., Fraser M.A., Holden S., et al. (2009). Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust, 190(9), 489– 492.

167.Zou H., Chen Y., Duan Z., et al. (2012). Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg- positive mothers. J Viral Hepat, 19(2), e18-25.

168.Hoang T.T.Q. (2019), Situation of Hepatitis B birth dose immunization in Vietnam and a proposed implementation research framework for identifying facilitators and barriers to Hepatitis B vaccine uptake, Thesis of master of Public Health, University of North Carolina.

169.Nguyen Si Anh H., Vo H.-L., Hoang Bao L., et al. (2019). Hepatitis B Birth Dose Vaccination among Vietnamese Children: Implications for the Expanded Program on Immunization. Biomed Res Int, 2019, 3453105.